Table 1

Synopsis highlighting the main features of adult cases (n=48) with coeliac crisis published so far

ReferenceAgeSexWeight lossFavorable evolution with GFDDiagnosisHLAHb (g/L)PLT (x109/L)INRHypo-proteinaemiaElectrolyte AbnormalitiesLOS (days)Death
Biopsy (Marsh grade)EMATG2 (UI/mL)
Ozaslan et al975MYesYesN/APositiveN/AN/A5997N/AYesYes10No
55FN/AYesN/APositiveN/AN/A7943N/AYesYes8No
Poudyal et al1020MNoYesN/AN/A100DQ886N/AN/ANoYesN/ANo
GutiƩrrez et al1126FN/AYes3cN/A23.4N/AN/AN/AN/AN/AN/AN/AN/A
Wolf et al1236FYesYes3cN/AN/AN/A<110N/AN/AN/AYesN/ANo
Forrest et al1543FYesYes3cN/A608N/A78<1002.1YesYes107No
Akbal et al1652FYesYesN/APositivePositiveN/A<100N/AN/AYesYesN/ANo
Al Shammeri et al1750FN/AYesN/A1/16015N/AN/AN/AN/AN/AYesN/ANo
Atikou et al1926FN/AYes3PositiveN/AN/AN/AN/AN/ANoYesN/ANo
Parry and Acharya2083MN/AYesN/APositive6N/AN/AN/AN/AN/AN/AN/ANo
Magro and Pullicino2138MYesYes3cN/A35.9N/A152N/A1.6YesYesN/ANo
Lindo Ricce et al2263FN/ANo3cN/A45DQ2N/AN/AN/AYesYes30No
de Almeida Menezes et al2531MYesYesN/AN/AN/AN/AN/AN/A3.48YesYes6No
Gonzalez et al2676MYesYesN/AN/AN/AN/A102N/A>10N/AYes10No
Da Costa Becker et al2749FYesYes3cPositivePositiveN/A72250>1.5YesYesN/ANo
Ferreira et al2856MYesYesN/AN/AN/ADQ2<110N/A>1.2NoYes7No
Helvaci et al2925FYesYes3cN/A100N/AN/AN/AN/AYesYes14No
Chen et al3024FYesYes3cN/A99N/A93N/A3.2NoYes8No
Sbai et al3143MYesYes3cN/A19N/AN/AN/AN/ANoYes5No
Bul et al3246MYesYesN/AN/A48N/A110N/AN/AYesNoN/ANo
Tiwari et al3326FN/AYesN/AN/A100N/A158N/AN/AYesYesN/ANo
Bou-Abboud et al3469MN/AYes3bN/A132N/A48N/A1.2YesYesN/ANo
Yilmaz et al3575MNoYesN/A3+PositiveN/A81180N/AYesYes6No
82FYesN/AN/A1+PositiveN/A76156N/AYesYes8No
Ribeiro do Vale et al3658MYesYes3c1/640142N/A116N/A1.6NoYes11No
Mrad et al3764FYesYes3cPositive200N/A87N/A>1.2YesYesN/ANo
Jamma et al3834FYesYes3bN/A113DQ8N/AN/AN/AN/AYes7No
51MYesYes3cN/A200DQ2N/AN/AN/AN/AYes11No
48FYesYes3bN/A0DQ2N/AN/AN/AN/AYes4No
70MYesYes3N/A100N/AN/AN/AN/AN/AYesN/ANo
48FYesN/A3N/AN/ADQ2N/AN/AN/AN/AYes7No
68FYesYes3N/A6DQ2N/AN/AN/AN/AYes5No
67FYesYes3cN/A250DQ2N/AN/AN/AN/AYes8No
74FYesYes3cN/A24.5N/AN/AN/AN/AN/ANo7No
65MYesYes3N/A21.3DQ2N/AN/AN/AN/AYes10No
68MYesYes3bN/A117DQ2N/AN/AN/AN/AYes11No
65FYesYes3cN/A22DQ2N/AN/AN/AN/ANo13No
49FYesYes3N/A83.7DQ2N/AN/AN/AN/AYes4No
Hammami et al3926FYesNoN/AN/AN/AN/AN/AN/AN/AYesYes7Yes
Toyoshima et al 4030FYesYesN/A1/12805N/A114N/AN/AYesYesN/ANo
Kelly et al4123FN/AYesN/AN/A33.9N/A12094N/AN/AYes21No
Krishna et al4267MYesYes3Negative4DQ8124160N/AYesYes15No
Chandan et al4358MYesYes3cN/A200N/A47N/AN/AYesYesN/ANo
Kizilgul et al4450MYesYes3158.7200N/A94N/AN/AN/AYesN/ANo
Selen et al4537FYesYes3PositivePositiveN/A80N/AN/AYesYesN/ANo
Gupta et al4630FYesYes3bN/AN/AN/A<110N/AN/AYesYes7No
Present Case34FYesYes3c1/8023DQ2852972,52YesYes9No
  • EMA, antiendomysial antibodies; F, female; GFD, gluten-free diet; Hb, haemoglobin; HLA, human leucocyte antigen; INR, international normalised ratio; LOS, length of stay; M, male; N/A, not applicable; PLT, platelets; TG2, tissue transglutaminase.